The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Cardiovascular Effect of the Uremic Solute Indole-3 Acetic Acid
Open accessAbstract
In CKD, uremic solutes may induce endothelial dysfunction, inflammation, and oxidative stress, leading to increased cardiovascular risk. We investigated whether the uremic solute indole-3 acetic acid (IAA) predicts clinical outcomes in patients with CKD and has prooxidant and proinflammatory effects. We studied 120 patients with CKD. During the median study period of 966 days, 29 patients died and 35 experienced a major cardiovascular event. Kaplan-Meier analysis revealed that mortality and cardiovascular events were significantly higher in the higher IAA group (IAA>3.73 µM) than in the lower IAA group (IAA<3.73 µM). Multivariate Cox regression analysis demonstrated that serum IAA was a significant predictor of mortality and cardiovascular events after adjustments for age and sex; cholesterol, systolic BP, and smoking; C-reactive protein, phosphate, body mass index, and albumin; diastolic BP and history of cardiovascular disease; and uremic toxins p-cresyl sulfate and indoxyl sulfate. Notably, IAA level remained predictive of mortality when adjusted for CKD stage. IAA levels were positively correlated with markers of inflammation and oxidative stress: C-reactive protein and malondialdehyde, respectively. In cultured human endothelial cells, IAA activated an inflammatory nongenomic aryl hydrocarbon receptor (AhR)/p38MAPK/NF-κB pathway that induced the proinflammatory enzyme cyclooxygenase-2. Additionally, IAA increased production of endothelial reactive oxygen species. In conclusion, serum IAA may be an independent predictor of mortality and cardiovascular events in patients with CKD. In vitro, IAA induces endothelial inflammation and oxidative stress and activates an inflammatory AhR/p38MAPK/NF-κB pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Self-citationNormal and Pathologic Concentrations of Uremic Toxins
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121175 · Cited by 961
Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., & Massy, Z. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03980609 · Cited by 929
Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
Cachofeiro, V., Goicochea, M., de Vinuesa, S. G., Oubiña, P., Lahera, V., & Luño, J. (2008) · Kidney International · doi:10.1038/ki.2008.516 · Cited by 662
Mitochondrial reactive oxygen species-mediated signaling in endothelial cells
Zhang, D. X., & Gutterman, D. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01283.2006 · Cited by 439
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
DOU, L., JOURDE‐CHICHE, N., FAURE, V., CERINI, C., BERLAND, Y., DIGNAT‐GEORGE, F., & BRUNET, P. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02540.x · Cited by 432
Self-citationLiabeuf, S., Barreto, D. V., Barreto, F. C., Meert, N., Glorieux, G., Schepers, E., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z. A., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp592 · Cited by 431
Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products
Félétou, M., Huang, Y., & Vanhoutte, P. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01276.x · Cited by 372
Cipollone, F., Prontera, C., Pini, B., Marini, M., Fazia, M., De Cesare, D., Iezzi, A., Ucchino, S., Boccoli, G., Saba, V., et al. (2001) · Circulation · doi:10.1161/hc3401.093152 · Cited by 351
Activation of the Ah Receptor by Tryptophan and Tryptophan Metabolites
Heath-Pagliuso, S., Rogers, W. J., Tullis, K., Seidel, S. D., Cenijn, P. H., Brouwer, A., & Denison, M. S. (1998) · Biochemistry · doi:10.1021/bi980087p · Cited by 331
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
Motojima, M., Hosokawa, A., Yamato, H., Muraki, T., & Yoshioka, T. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00906.x · Cited by 278
Gondouin, B., Cerini, C., Dou, L., Sallée, M., Duval-Sabatier, A., Pletinck, A., Calaf, R., Lacroix, R., Jourde-Chiche, N., Poitevin, S., et al. (2013) · Kidney International · doi:10.1038/ki.2013.133 · Cited by 253
Self-citationWu, I.-W., Hsu, K.-H., Hsu, H.-J., Lee, C.-C., Sun, C.-Y., Tsai, C.-J., & Wu, M.-S. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr453 · Cited by 210
Induction of cellular oxidative stress by aryl hydrocarbon receptor activation
Dalton, T. P., Puga, A., & Shertzer, H. G. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00067-4 · Cited by 188
Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial Dysfunction
Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., & Brunet, P. (2011) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2011.00925.x · Cited by 187
Self-citationWu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., Van Winkle, L., Matsumura, F., & Vogel, C. F. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.220202 · Cited by 187
The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Cardiovascular Diseases
Korashy, H. M., & El-Kadi, A. O. S. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600632063 · Cited by 173
Haarmann-Stemmann, T., Bothe, H., & Abel, J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.013 · Cited by 169
PROGRESS IN UREMIC TOXIN RESEARCH: Protein‐Bound Toxins—Update 2009
Jourde‐Chiche, N., Dou, L., Cerini, C., Dignat‐George, F., Vanholder, R., & Brunet, P. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00576.x · Cited by 159
Self-citationUpdate on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins
Watanabe, H., Miyamoto, Y., Otagiri, M., & Maruyama, T. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22592 · Cited by 145
Kopf, P. G., & Walker, M. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.007 · Cited by 127
Cipollone, F., Cicolini, G., & Bucci, M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.002 · Cited by 127
Smet, R. D., Dhondt, A., Eloot, S., Galli, F., Waterloos, M., & Vanholder, R. C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm065 · Cited by 103
New insights into uremic toxicity
Raff, A. C., Meyer, T. W., & Hostetter, T. H. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32830f45b6 · Cited by 91
Eloot, S., Schepers, E., Barreto, D. V., Barreto, F. C., Liabeuf, S., Biesen, W. V., Verbeke, F., Glorieux, G., Choukroun, G. J., Massy, Z. A., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09981110 · Cited by 87
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
Liabeuf, S., Glorieux, G., Lenglet, A., Diouf, M., Schepers, E., Desjardins, L., Choukroun, G. J., Vanholder, R. C., Massy, Z. A., & on behalf of the European Uremic Toxin (EUTox) Work Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0067168 · Cited by 85
Tardieu, D. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.973 · Cited by 85
Calaf, R., Cérini, C., Genovesio, C., Verhaeghe, P., Jourde‐Chiche, N., Bergé‐Lefranc, D., Gondouin, B., Dou, L., Morange, S., Argilés, À., et al. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.06.014 · Cited by 85
Self-citationBrandenburg, V. M., Schlieper, G., Heussen, N. M., Holzmann, S., Busch, B., Evenepoel, P., Vanholder, R., Meijers, B. K. I., Meert, N., Faßbender, W. J., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq053 · Cited by 83
Lin, C., Hsieh, H., Shih, R., Chi, P., Cheng, S., & Yang, C. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-8 · Cited by 82
Does the Adequacy Parameter Kt/Vurea Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
Eloot, S., Biesen, W. V., Glorieux, G., Neirynck, N., Dhondt, A., & Vanholder, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076838 · Cited by 72
Hsieh, H., Lin, C., Chan, H., Yang, C. M., & Yang, C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-152 · Cited by 60
PROGRESS IN UREMIC TOXIN RESEARCH: Platelet/Leukocyte Activation, Inflammation, and Uremia
Glorieux, G., Cohen, G., Jankowski, J., & Vanholder, R. C. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00593.x · Cited by 53
Degner, S. C., Kemp, M. Q., Hockings, J. K., & Romagnolo, D. F. (2007) · Nutrition and Cancer · doi:10.1080/01635580701485585 · Cited by 47
Effect of Exercise on Cardiac Tissue Oxidative and Inflammatory Mediators in Chronic Kidney Disease
Bai, Y., Sigala, W., Adams, G. R., & Vaziri, N. D. (2008) · American Journal of Nephrology · doi:10.1159/000156715 · Cited by 47
Dong, B., Nishimura, N., Vogel, C. F. A., Tohyama, C., & Matsumura, F. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.031 · Cited by 45
NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
Caballo, C., Palomo, M., Cases, A., Galan, A. M., Molina, P., Vera, M., Bosch, X., Escolar, G., & Díaz‐Ricart, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043374 · Cited by 43
Li, W., Vogel, C. F. A., Wu, D., & Matsumura, F. (2010) · Biological Chemistry · doi:10.1515/bc.2010.126 · Cited by 34
ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta
Vaziri, N. D., Bai, Y., Yuan, J. J., Said, H. L., Sigala, W., & Ni, Z. (2010) · American Journal of Nephrology · doi:10.1159/000316479 · Cited by 21
van der Giet, M., Tölle, M., Praticò, D., Lufft, V., Schuchardt, M., Hörl, M. P., Zidek, W., & Tietge, U. J. F. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0543-3 · Cited by 14
Cited by
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Self-citationZoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
Ramezani, A., Massy, Z. A., Meijers, B., Evenepoel, P., Vanholder, R., & Raj, D. S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.09.027 · Cited by 394
“Plasma IAA concentrations are elevated in CKD and the compound is only partly removed during hemodialysis.70 IAA has been shown to induce glomerular sclerosis and interstitial fibrosis in subtotally nephrectomized rats, thus contributing to the progression of CKD.71 IAA is also a significant predictor of mortality and…”
BackgroundInfluentialBiochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
The Impact of CKD on Uremic Toxins and Gut Microbiota
Rysz, J., Franczyk, B., Ławiński, J., Olszewski, R., Ciałkowska-Rysz, A., & Gluba-Brzózka, A. (2021) · Toxins · doi:10.3390/toxins13040252 · Cited by 307
Metadata
- Authors
- Dou, L., Sallée, M., Cerini, C., Poitevin, S., Gondouin, B., Jourde-Chiche, N., Fallague, K., Brunet, P., Calaf, R., Dussol, B., Mallet, B., Dignat-George, F., & Burtey, S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-04
- Volume
- 26
- Issue
- 4
- Pages
- 876-887
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2155352361
- Cited by
- 329
- References
- 42
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.